Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Skin Rejuvenation Technologies is a South African biotechnology company that develops and manufactures advanced cosmeceutical products under the flagship brand Optiphi. The company focuses on cellular rejuvenation and skin longevity by utilizing high concentrations of active ingredients, including peptides, alpha hydroxy acids, and DNA repair enzymes. Their research-driven approach targets the underlying mechanisms of skin aging, hyperpigmentation, and environmental damage. SRT operates its own specialized manufacturing and R&D facilities to ensure clinical-grade efficacy across its professional and retail product lines. The company is a prominent player in the medical aesthetics market, providing solutions for both dermatological recovery and long-term skin health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Skin Rejuvenation Technologies.